Advertisement

Oestrogen Replacement Therapy

  • Bob Yang
  • Steve FoleyEmail author
Chapter
Part of the In Clinical Practice book series (ICP)

Abstract

After menopause, oestrogen levels within a women’s body decrease. The vagina is normally colonised with Lactobacillus, a type of “good bacteria”, and their levels are maintained by oestrogen. Lactobacillus creates lactic acid, thus producing an acidic microenvironment within the vagina, protecting against harmful uropathogens from colonising. The loss of this oestrogen stimulation decreases the levels of lactobacillus within the vaginal wall epithelium, and thus the usual low pH acidic environment is lost, increasing the risk of UTIs in post-menopausal women.

References

  1. 1.
    Perrotta C, Aznar M, Mejia R, Albert X, Ng CW. Oestrogens for preventing recurrent urinary tract infection in postmenopausal women. Obstet Gynecol. 2008;112(3):689–90.CrossRefGoogle Scholar
  2. 2.
    Raz R. Hormone replacement therapy or prophylaxis in postmenopausal women with recurrent urinary tract infection. J Infect Dis. 2001;183(Suppl 1):S74–6.CrossRefGoogle Scholar
  3. 3.
    Cardozo L, Lose G, McClish D, Versi E, de Koning Gans H. A systematic review of estrogens for recurrent urinary tract infections: third report of the hormones and urogenital therapy (HUT) committee. Int Urogynecol J Pelvic Floor Dysfunct. 2001;12(1):15–20.CrossRefGoogle Scholar
  4. 4.
    Sood R, Faubion SS, Kuhle CL, Thielen JM, Shuster LT. Prescribing menopausal hormone therapy: an evidence-based approach. Int J Womens Health. 2014;6:47–57.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  1. 1.Royal Berkshire HospitalReading, GBUK

Personalised recommendations